The liver's dance with death: Two Bcl-2 guardian proteins from the abyss

Hepatology

Volumn 50, Issue 4, 2009, Pages 1009-1013

  Cazanave, Sophie C ^a   Gores, Gregory J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; BH3 PROTEIN; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN MCL 1; BCL2L1 PROTEIN, MOUSE; DEATH RECEPTOR; MYELOID CELL LEUKEMIA SEQUENCE 1 PROTEIN; PROTEIN BCL X; PROTEIN BID;

AMINO TERMINAL SEQUENCE; APOPTOSIS; CELL DEATH; CELL FUNCTION; CELL PROTECTION; CELL STIMULATION; CELL STRESS; CELL SURVIVAL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EDITORIAL; HUMAN; LIVER CELL; LIVER DISEASE; LIVER FAILURE; LIVER FUNCTION; LIVER MITOCHONDRION; LIVER PROTECTION; LIVER TOXICITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; SEQUENCE HOMOLOGY; ANIMAL; LIVER; METABOLISM; MOUSE; MOUSE MUTANT; NOTE; PATHOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; HEPATOCYTES; LIVER; MICE; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, DEATH DOMAIN;

EID: 70350048553     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.23188     Document Type: Editorial

References (38)

1. Kim WR, Flamm SL, Di Bisceglie AM, Bodenheimer HC. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. HEPATOLOGY 2008;47:1363-1370.
2. Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 2008;9:231-241.
3. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-257.
4. Wyllie AH, Kerr JF, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980;68:251-306.
5. Guicciardi ME, Gores GJ. Life and death by death receptors. FASEB J 2009;23:1625-1637.
6. Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008;9:47-59.
7. Gallenne T, Gautier F, Oliver L, Hervouet E, Noel B, Hickman JA, et al. Bax activation by the BH3-only protein Puma promotes cell dependence on antiapoptotic Bcl-2 family members. J Cell Biol 2009;185:279-290.
8. Gavathiotis E, Suzuki M, Davis ML, Pitter K, Bird GH, Katz SG, et al. BAX activation is initiated at a novel interaction site. Nature 2008;455:1076-1081.
9. Walensky LD, Pitter K, Morash J, Oh KJ, Barbuto S, Fisher J, et al. A stapled BID BH3 helix directly binds and activates BAX. Mol Cell 2006;24:199-210.
10. Adams JM, Cory S. Bcl-2-regulated apoptosis: mechanism and therapeutic potential. Curr Opin Immunol 2007;19:488-496.
11. Tzung SP, Fausto N, Hockenbery DM. Expression of Bcl-2 family during liver regeneration and identification of Bcl-x as a delayed early response gene. Am J Pathol 1997;150:1985-1995.
12. Hamasaki A, Sendo F, Nakayama K, Ishida N, Negishi I, Nakayama K, et al. Accelerated neutrophil apoptosis in mice lacking A1-a, a subtype of the bcl-2-related A1 gene. J Exp Med 1998;188:1985-1992.
13. Print CG, Loveland KL, Gibson L, Meehan T, Stylianou A, Wreford N, et al. Apoptosis regulator bcl-w is essential for spermatogenesis but appears otherwise redundant. Proc Natl Acad Sci U S A 1998;95:12424-12431.
14. Ross AJ, Waymire KG, Moss JE, Parlow AF, Skinner MK, Russell LD, et al. Testicular degeneration in Bclw-deficient mice. Nat Genet 1998;18:251-256.
15. Takehara T, Tatsumi T, Suzuki T, Rucker EB 3rd, Hennighausen L, Jinushi M, et al. Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses. Gastroenterology 2004;127:1189-1197.
16. Vick B, Weber A, Urbanik T, Maass T, Teufel A, Krammer PH, et al. Knock-out of myeloid cell leukemia-1 induces liver damage and increases apoptosis susceptibility of murine hepatocytes. HEPATOLOGY 2009;49:627-636.
17. Hikita H, Takehara T, Shimizu S, Kodama T, Li W, Miyagi T, et al. Mcl-1 and Bcl-xL cooperatively maintain integrity of hepatocytes in developing adult liver. HEPATOLOGY 2009;50:1217-1226.
18. Yin XM. Bid, a BH3-only multi-functional molecule, is at the cross road of life and death. Gene 2006;369:7-19.
19. Yoon JH, Gores GJ. Death receptor-mediated apoptosis and the liver. J Hepatol 2002;37:400-410.
20. Yin XM, Wang K, Gross A, Zhao Y, Zinkel S, Klocke B, et al. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 1999;400:886-891.
21. Kaufmann T, Jost PJ, Pellegrini M, Puthalakath H, Gugasyan R, Gerondakis S, et al. Fatal hepatitis mediated by tumor necrosis factor TNFalpha requires caspase-8 and involves the BH3-only proteins Bid and Bim. Immunity 2009;30:56-66.
22. Luedde T, Trautwein C. Intracellular survival pathways in the liver. Liver Int 2006;26:1163-1174.
23. Gores GJ, Kaufmann SH. Is TRAIL hepatotoxic? HEPATOLOGY 2001;34:3-6.
24. Baskin-Bey ES, Huang W, Ishimura N, Isomoto H, Bronk SF, Braley K, et al. Constitutive androstane receptor (CAR) ligand, TCPOBOP, attenuates Fas-induced murine liver injury by altering Bcl-2 proteins. HEPATOLOGY 2006;44:252-262.
25. de la Coste A, Fabre M, McDonell N, Porteu A, Gilgenkrantz H, Perret C, et al. Differential protective effects of Bcl-xL and Bcl-2 on apoptotic liver injury in transgenic mice. Am J Physiol 1999;277:G702-G708.
26. Zhang H, Taylor J, Luther D, Johnston J, Murray S, Wyatt JR, et al. Antisense oligonucleotide inhibition of Bcl-xL and Bid expression in liver regulates responses in a mouse model of Fas-induced fulminant hepatitis. J Pharmacol Exp Ther 2003;307:24-33.
27. Corazza N, Jakob S, Schaer C, Frese S, Keogh A, Stroka D, et al. TRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality. J Clin Invest 2006;116:2493-2499.
28. Gelinas C, White E. BH3-only proteins in control: specificity regulates MCL-1 and BAK-mediated apoptosis. Genes Dev 2005;19:1263-1268.
29. Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG, et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 2005;17:393-403.
30. Clohessy JG, Zhuang J, de Boer J, Gil-Gomez G, Brady HJ. Mcl-1 interacts with truncated Bid and inhibits its induction of cytochrome c release and its role in receptor-mediated apoptosis. J Biol Chem 2006;281:5750-5759.
31. Deng J, Carlson N, Takeyama K, Dal Cin P, Shipp M, Letai A. BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents. Cancer Cell 2007;12:171-185.
32. Mason KD, Carpinelli MR, Fletcher JI, Collinge JE, Hilton AA, Ellis S, et al. Programmed anuclear cell death delimits platelet life span. Cell 2007;128:1173-1186.
33. Del Gaizo Moore V, Brown JR, Certo M, Love TM, Novina CD, Letai A. Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737. J Clin Invest 2007;117:112-121.
34. Kobayashi S, Lee SH, Meng XW, Mott JL, Bronk SF, Werneburg NW, et al. Serine 64 phosphorylation enhances the antiapoptotic function of Mcl-1. J Biol Chem 2007;282:18407-18417.
35. Deverman BE, Cook BL, Manson SR, Niederhoff RA, Langer EM, Rosova I, et al. Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage. Cell 2002;111:51-62.
36. Upreti M, Galitovskaya EN, Chu R, Tackett AJ, Terrano DT, Granell S, et al. Identification of the major phosphorylation site in Bcl-xL induced by microtubule inhibitors and analysis of its functional significance. J Biol Chem 2008;283:35517-35525.
37. Lei K, Davis RJ. JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc Natl Acad Sci U S A 2003;100:2432-2437.
38. Chen D, Zhou Q. Caspase cleavage of BimEL triggers a positive feedback amplification of apoptotic signaling. Proc Natl Acad Sci U S A 2004;101:1235-1240.